Literature DB >> 8459517

Shingles. Sorrows, salves, and solutions.

S E Straus1.   

Abstract

Mesh：

Substances：

Year:  1993        PMID： 8459517     DOI： 10.1001/jama.269.14.1836

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  7 in total

Review 1.  Antiviral therapies for herpes zoster infections. Are they economically justifiable?

Authors:  K J Smith; M S Roberts
Journal:  Pharmacoeconomics       Date:  2000-08       Impact factor: 4.981

2.  The cellular localization pattern of Varicella-Zoster virus ORF29p is influenced by proteasome-mediated degradation.

Authors:  Christina L Stallings; Gregory J Duigou; Anne A Gershon; Michael D Gershon; Saul J Silverstein
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

3.  The cost of treatment for post-herpetic neuralgia in the UK.

Authors:  L Davies; L Cossins; D Bowsher; M Drummond
Journal:  Pharmacoeconomics       Date:  1994-08       Impact factor: 4.981

4.  Dissection of a novel nuclear localization signal in open reading frame 29 of varicella-zoster virus.

Authors:  Christina L Stallings; Saul Silverstein
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

5.  Reactivated and latent varicella-zoster virus in human dorsal root ganglia.

Authors:  O Lungu; P W Annunziato; A Gershon; S M Staugaitis; D Josefson; P LaRussa; S J Silverstein
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

Review 6.  Antiviral therapy of acute herpes zoster in older patients.

Authors:  K Herne; R Cirelli; P Lee; S K Tyring
Journal:  Drugs Aging       Date:  1996-02       Impact factor: 3.923

7.  Aberrant intracellular localization of Varicella-Zoster virus regulatory proteins during latency.

Authors:  O Lungu; C A Panagiotidis; P W Annunziato; A A Gershon; S J Silverstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.